Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).

TSXV:SBM - Post by User

Sirona Biochem Corp > This sounds pretty good to me

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Jun 20, 2024 10:43am

83 Views

Post# 36097822

RE:RE:RE:RE:This sounds pretty good to me

MirrorWorldMan wrote: Smokescreen to distract from AbbVie deal which is considered dead, or we would be trading higher. See it all the time with micro cap biotechs. Issue fodder of future pipeline breakthroughs to cover up past and current failures.

Maybe AbbVie bought it just for that express thought of putting it on the shelf for a considerable period of time. Keep it out of the market while they market something else.

Why not a conspiracy theory thrown in? :-))

<< Previous

Bullboard Posts

Next >>

Catch up with companies that got a Stanley Cup Playoffs boost